RESTON, Va.--(BUSINESS WIRE)--Aptiv Solutions, a biopharmaceutical and medical device development services company, and leader in adaptive clinical trial design, simulation and execution, announced today several key appointments and promotions to strengthen the Company’s focus and leadership in providing adaptive clinical trial services.

“I am pleased to be surrounded with such talented experts who will facilitate the acceptance of adaptive clinical trials into the development process for pharmaceutical, biotechnology and medical device products.”

Corey Dunham has been promoted to Senior Vice President of Global Data Management. Mr. Dunham serves on the technology team responsible for the growth and development of AptivAdvantage™, the Company’s integrated technology platform. AptivAdvantage™ offers sponsors a robust and seamless adaptive design, web randomization, drug supply and electronic data capture (EDC) platform to facilitate optimal clinical trial execution. Mr. Dunham will play a leadership role in helping clients understand the requirements for successful implementation of complex adaptive clinical trials. Prior to this promotion, Mr. Dunham led the US Data Management team.

Dr. Martin Geueke has been appointed to the newly-created position of Senior Vice President of Software Development. Dr. Geueke will lead a global team dedicated to the development of new software to support adaptive clinical trial execution, including customized applications to support specific client requirements. Dr. Geueke has over 16 years of experience in clinical data management, software development and information technology. He has spent the past 12 years developing EDC systems, including iCRF, the proprietary EDC system developed by Aptiv Solutions and predecessor to AptivAdvantage™. Prior to this position, Dr. Geueke led the European Data Management team at Aptiv Solutions.

Christopher Ellis has been appointed to the newly created position of Vice President, Project Management Europe. Mr. Ellis joined Aptiv Solutions with the recent SRA GCD acquisition. With the momentum growing in the execution of adaptive clinical trials, Mr. Ellis will lead project management efforts with a focus on practices and methodology for adaptive trial implementation and execution.

Angela Weston has been promoted to Senior Vice President of Business Development Europe. Ms. Weston and her team will continue to promote and market the adaptive clinical trial design expertise and implementation services offered by Aptiv Solutions to the biopharmaceutical industry in Europe.

“Having this team in place is critical for Aptiv Solutions to realize its vision of being the market leader in adaptive clinical trial design, simulation and execution.” said Pat Donnelly, Chairman and Chief Executive Officer at Aptiv Solutions. “I am pleased to be surrounded with such talented experts who will facilitate the acceptance of adaptive clinical trials into the development process for pharmaceutical, biotechnology and medical device products.”

About Aptiv Solutions

Aptiv Solutions is a global biopharmaceutical and medical device development services company focused on recognizing, understanding and enabling clients to capitalize on rapid and fundamental changes facing companies developing products in the pharmaceutical, biotech and medical device market. The company offers clients an extensive portfolio of innovative services including adaptive clinical trials, translational research services, regulatory services, pharmacovigilance, clinical staffing and the operational support of a global clinical research organization. Aptiv Solutions has over 850 professionals in North America, Europe, the Middle East, Japan, and Australia. Visit the website at www.aptivsolutions.com
Contacts

Aptiv Solutions
Gillian DellaCioppa, +1 508-597-6000
Director of Marketing
inquiry@aptivsolutions.com